Galectin-2 3279TT variant protects against the lymphotoxin-α 252GG genotype associated ischaemic stroke

Clinical Neurology and Neurosurgery

Volumn 111, Issue 3, 2009, Pages 227-230

  Szolnoki, Zoltan ^a   Maasz, Anita ^b   Magyari, Lili ^b   Horvatovich, Katalin ^b   Farago, Bernadett ^b   Kondacs, Andras ^a   Bodor, Anita ^c   Hadarits, Ferenc ^d   Orosz, Peter ^a   Ille, Alexandru ^a   Melegh, Bela ^b,e  

^a Pandy Kalman County Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Rethy Pal County Hospital   (Hungary)

^d Markusovszky Teaching Hospital   (Hungary)

^e UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Galectin 2; Genetic interaction; LGALS2 3279TT variant; LTA 252GG; Lymphotoxin alpha; Stroke

Indexed keywords

GALECTIN 2; LYMPHOTOXIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING;

EID: 60349124928     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.09.027     Document Type: Article

References (18)

1. Messer G., Spengler U., and Jung M.C. Polymorphic structure of the tumor necrosis factor(TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173 (1991) 209-219
2. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., and Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93 (1996) 672-682
3. Squadrito F., Saitta A., and Altavilla D. Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction. Inflamm Res 45 (1996) 14-19
4. Belch J.J., Shaw J.W., and Kirk G. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 95 (1997) 2027-2031
5. Hwang S.J., Ballantyne C.M., and Sharrett A.R. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 (1997) 4219-4225
6. Morisaki N., Saito I., and Tamura K. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 131 (1997) 43-48
7. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999) S419-S420
8. Schreyer S.A., Vick C.M., and LeBoeuf R.C. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 277 (2002) 12364-12368
9. Ozaki K., Ohnishi Y., and Iida A. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32 (2002) 650-654
10. Szolnoki Z., Havasi V., and Talian G. Lymphotoxin-α gene 252 G allelic variant is a risk factor for large-vessel-associated ischemic stroke. J Mol Neurosci 27 (2005) 205-211
11. Wang Q. Molecular genetics of coronary artery disease. Curr Opin Cardiol 20 (2005) 182-188 [Review]
12. Wang Q. Advances in the genetic basis of coronary artery disease. Curr Atheroscler Rep 7 (2005) 235-241 [Review]
13. Topol E.J., Smith J., Plow E.F., and Wang Q.K. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet Spec No 2 (2006) R117-R123
14. Mizuno H., Sato H., Sakata Y., and Ohnishi Y. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 185 (2006) 400-405
15. Liu Y., Herrington D., and Burdon K.P. A functional polymorphism in the lymphotoxin-alpha gene is associated with artery wall thickness: the diabetes heart study. Eur J Cardiovasc Prev Rehabil 13 (2006) 655-657
16. Um J.Y., An N.H., and Kim S.H. Genetic susceptibility to ischemic cerebrovascular disease in Koreans. J Mol Neurosci 20 (2003) 31-38
17. Ozaki K., Inoue K., and Sato H. Functional variation in LGALS2 confers risk of myocardial infaction and regulates lymphotoxin-α secretin in vitro. Nature 429 (2004) 72-75
18. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., and Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 249 (2002) 1391-1397